Smart Nanoparticles for Breast Cancer Treatment Based on the Tumor Microenvironment
- PMID: 35720010
- PMCID: PMC9204624
- DOI: 10.3389/fonc.2022.907684
Smart Nanoparticles for Breast Cancer Treatment Based on the Tumor Microenvironment
Abstract
Breast cancer (BC) is the most common malignant tumor in women. There are different risk characteristics and treatment strategies for different subtypes of BC. The tumor microenvironment (TME) is of great significance for understanding the occurrence, development, and metastasis of tumors. The TME plays an important role in all stages of BC metastasis, immune monitoring, immune response avoidance, and drug resistance, and also plays an important role in the diagnosis, prevention, and prognosis of BC. Smart nanosystems have broad development prospect in the regulation of the BC drug delivery based on the response of the TME. In particular, TME-responsive nanoparticles cleverly utilize the abnormal features of BC tissues and cells to achieve targeted transport, stable release, and improved efficacy. We here present a review of the mechanisms underlying the response of the TME to BC to provide potential nanostrategies for future BC treatment.
Keywords: drug delivery; nanobiosensors; nanomaterial; nanotechnology; smart nanoparticles; tumor microenvironment.
Copyright © 2022 Luo, Zhang, Chen, Hou, Zeng and Wu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.Molecules. 2021 May 5;26(9):2703. doi: 10.3390/molecules26092703. Molecules. 2021. PMID: 34062992 Free PMC article. Review.
-
Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer.Front Oncol. 2021 Nov 15;11:766248. doi: 10.3389/fonc.2021.766248. eCollection 2021. Front Oncol. 2021. PMID: 34868991 Free PMC article. Review.
-
Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.J Control Release. 2021 May 10;333:374-390. doi: 10.1016/j.jconrel.2021.03.039. Epub 2021 Mar 30. J Control Release. 2021. PMID: 33798666 Review.
-
Insights into the potential of Sanguinarine as a promising therapeutic option for breast cancer.Biochem Pharmacol. 2023 Jun;212:115565. doi: 10.1016/j.bcp.2023.115565. Epub 2023 Apr 20. Biochem Pharmacol. 2023. PMID: 37086811 Review.
-
Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance.Pharmaceutics. 2024 Dec 3;16(12):1549. doi: 10.3390/pharmaceutics16121549. Pharmaceutics. 2024. PMID: 39771528 Free PMC article. Review.
Cited by
-
Recent advances in photothermal therapy-based multifunctional nanoplatforms for breast cancer.Front Chem. 2022 Sep 19;10:1024177. doi: 10.3389/fchem.2022.1024177. eCollection 2022. Front Chem. 2022. PMID: 36199665 Free PMC article. Review.
-
Polymeric Micelle-Based Nanogels as Emerging Drug Delivery Systems in Breast Cancer Treatment: Promises and Challenges.Curr Drug Targets. 2024;25(10):649-669. doi: 10.2174/0113894501294136240610061328. Curr Drug Targets. 2024. PMID: 38919076 Review.
-
Gold nanoparticles combined baker's yeast as a successful approach for breast cancer treatment.J Genet Eng Biotechnol. 2023 Mar 6;21(1):27. doi: 10.1186/s43141-023-00481-1. J Genet Eng Biotechnol. 2023. PMID: 36877301 Free PMC article.
-
Injectable Nano Drug Delivery Systems for the Treatment of Breast Cancer.Pharmaceutics. 2022 Dec 13;14(12):2783. doi: 10.3390/pharmaceutics14122783. Pharmaceutics. 2022. PMID: 36559276 Free PMC article. Review.
-
Metastatic Breast Cancer: Review of Emerging Nanotherapeutics.Cancers (Basel). 2023 May 25;15(11):2906. doi: 10.3390/cancers15112906. Cancers (Basel). 2023. PMID: 37296869 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources